Wuhan Easy Diagnosis Biomedicine Co LtdWuhan Easy Diagnosis Biomedicine Co Ltd - ESG Rating & Company Profile powered by AI

Industry Group:Medical Equipment, Supplies & Distribution

This page displays a zero-cost Environmental, Social and Governance analysis covering Wuhan Easy Diagnosis Biomedicine Co Ltd. Complete Sustainability analysis of Wuhan Easy Diagnosis Biomedicine Co Ltd are accessed by signing up for free. Other corporations in the rating peer group for Wuhan Easy Diagnosis Biomedicine Co Ltd are displayed below.

Wuhan Easy Diagnosis Biomedicine Co Ltd in the Medical Equipment, Supplies & Distribution industry gained a UN SDG ESG Transparency Score of 2.7; made up of an environmental score of 2.7, social score of 2.3 and governance score of 3.0.

SDG Transparency Score for Wuhan Easy Diagnosis Biomedicine Co Ltd 

2.7

Low Impact
0 - 3
Medium
4 - 6
High
7 - 10
Last Score Update: 2023-07-01
What drives the score for Wuhan Easy Diagnosis Biomedicine Co Ltd 
2.7

Environmental

2.3

Social

3.0

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Becton Dickinson and Co
8.6
High
2DENTSPLY SIRONA Inc
8.4
High
.........
331PlexBio Co Ltd
2.8
Medium
331Redsense Medical AB (publ)
2.8
Medium
345Wuhan Easy Diagnosis Biomedicine Co Ltd
2.7
Medium
345MITech Co Ltd
2.7
Medium
345GTG Wellness Co Ltd
2.7
Medium
.........
526Valeritas Holdings Inc
0.0
Low
526ZoomMed Inc
0.0
Low
.........
View the full peer group of 681 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does Wuhan Easy Diagnosis Biomedicine Co Ltd have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does Wuhan Easy Diagnosis Biomedicine Co Ltd disclose current and historical energy intensity?

LockedSign up for free to unlock

Does Wuhan Easy Diagnosis Biomedicine Co Ltd report the average age of the workforce?

LockedSign up for free to unlock

Does Wuhan Easy Diagnosis Biomedicine Co Ltd reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does Wuhan Easy Diagnosis Biomedicine Co Ltd disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does Wuhan Easy Diagnosis Biomedicine Co Ltd disclose cybersecurity risks?

LockedSign up for free to unlock

Does Wuhan Easy Diagnosis Biomedicine Co Ltd offer flexible work?

LockedSign up for free to unlock

Does Wuhan Easy Diagnosis Biomedicine Co Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does Wuhan Easy Diagnosis Biomedicine Co Ltd disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does Wuhan Easy Diagnosis Biomedicine Co Ltd conduct supply chain audits?

LockedSign up for free to unlock

Does Wuhan Easy Diagnosis Biomedicine Co Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does Wuhan Easy Diagnosis Biomedicine Co Ltd conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does Wuhan Easy Diagnosis Biomedicine Co Ltd disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does Wuhan Easy Diagnosis Biomedicine Co Ltd disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does Wuhan Easy Diagnosis Biomedicine Co Ltd disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does Wuhan Easy Diagnosis Biomedicine Co Ltd disclose water use targets?

LockedSign up for free to unlock

Does Wuhan Easy Diagnosis Biomedicine Co Ltd have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did Wuhan Easy Diagnosis Biomedicine Co Ltd have a product recall in the last two years?

LockedSign up for free to unlock

Does Wuhan Easy Diagnosis Biomedicine Co Ltd disclose incidents of discrimination?

LockedSign up for free to unlock

Does Wuhan Easy Diagnosis Biomedicine Co Ltd allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has Wuhan Easy Diagnosis Biomedicine Co Ltd issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does Wuhan Easy Diagnosis Biomedicine Co Ltd disclose parental leave metrics?

LockedSign up for free to unlock

Does Wuhan Easy Diagnosis Biomedicine Co Ltd disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does Wuhan Easy Diagnosis Biomedicine Co Ltd disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does Wuhan Easy Diagnosis Biomedicine Co Ltd disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does Wuhan Easy Diagnosis Biomedicine Co Ltd support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does Wuhan Easy Diagnosis Biomedicine Co Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does Wuhan Easy Diagnosis Biomedicine Co Ltd reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is Wuhan Easy Diagnosis Biomedicine Co Ltd involved in embryonic stem cell research?

LockedSign up for free to unlock

Does Wuhan Easy Diagnosis Biomedicine Co Ltd disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does Wuhan Easy Diagnosis Biomedicine Co Ltd disclose its waste policy?

LockedSign up for free to unlock

Does Wuhan Easy Diagnosis Biomedicine Co Ltd report according to TCFD requirements?

LockedSign up for free to unlock

Does Wuhan Easy Diagnosis Biomedicine Co Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does Wuhan Easy Diagnosis Biomedicine Co Ltd disclose energy use targets?

LockedSign up for free to unlock

Does Wuhan Easy Diagnosis Biomedicine Co Ltd disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does Wuhan Easy Diagnosis Biomedicine Co Ltd have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for Wuhan Easy Diagnosis Biomedicine Co Ltd
These potential risks are based on the size, segment and geographies of the company.

Wuhan Easy Diagnosis Biomedicine Co.,Ltd. engages in the research and development, production, and sale of in vitro diagnostic reagents and diagnostic equipment in China and internationally. Its products portfolio includes molecular diagnostic products, such as drug metabolism genetic testing and pathogen nucleic acid detection kits; and immunodiagnostic and blood gas diagnosis products. The company also provides emergency and critical illness information solutions, including information software products, supporting hardware, and certification consulting services; and third-party medical inspection services. It offers products in the areas of cardiovascular, kidney, infectious, diabetes, endocrine and metabolic, obstetrics, and gynecology diseases, as well as prenatal and postnatal care, health checkups, thyroid, hormones, blood gas, coagulation, drug metabolism, pathogen detection. The company was founded in 2008 and is based in Wuhan, China.

Sorry!

Failed to process!